Related Subjects:
| Metabolic Acidosis
| Lactic Acidosis
| Acute Kidney Injury (AKI)
About š§¾
- Gitelmanās Syndrome: A rare inherited tubulopathy of the distal convoluted tubule, caused by mutations affecting the thiazide-sensitive NaCl cotransporter (SLC12A3 gene).
- Often described as a ābenign Bartterās variantā but has key biochemical differences.
- Autosomal recessive inheritance ā manifests usually in late childhood or adulthood.
Clinical Features š©āāļø
- š¤ Chronic fatigue, weakness, and muscle cramps due to electrolyte imbalance.
- š Nocturia and polyuria (salt wasting leads to impaired concentrating ability).
- š Hypotension or lowānormal blood pressure (despite RAAS activation).
- Symptoms often milder than Bartterās and sometimes discovered incidentally on blood tests.
Investigations š¬
- Hypokalaemia š”: Potassium loss ā muscle weakness, cramps, arrhythmia risk.
- Metabolic Alkalosis š§Ŗ: Due to renal hydrogen ion loss.
- Salt Wasting š§: Renal sodium loss ā mild volume depletion.
- Hypomagnesaemia šµ: Characteristic and often symptomatic (tremors, cramps).
- Urinary Chloride ā: Consistently high, differentiates from surreptitious diuretic use.
- Calcium: Unlike Bartterās, Gitelmanās is associated with hypocalciuria (ā urinary calcium).
Key Differentiation š Bartterās
- Bartterās: Presents earlier in life, with hypercalciuria and often nephrocalcinosis.
- Gitelmanās: Later onset, with hypocalciuria and prominent hypomagnesaemia.
Management āļø
- š Electrolyte Replacement: Oral potassium and magnesium supplements are cornerstone therapy.
- š„¤ Liberal salt intake to counteract chronic salt wasting.
- š”ļø Potassium-sparing agents: Spironolactone, eplerenone, or amiloride to reduce renal Kāŗ loss.
- š« NSAIDs: Unlike Bartterās syndrome, NSAIDs are not useful in Gitelmanās.
Clinical Pearl š”
Think of Gitelmanās in a young adult with chronic cramps, fatigue, hypokalaemia, and low urinary calcium.
š āHypo-K, Hypo-Mg, Hypocalciuriaā = Gitelmanās.
Cases ā Gitelmanās Syndrome
- Case 1 ā Adolescent with cramps š¦: A 15-year-old boy presents with recurrent muscle cramps, fatigue, and occasional dizziness. Exam: normal blood pressure. Bloods: hypokalaemia, hypomagnesaemia, metabolic alkalosis, low urinary calcium. Diagnosis: Gitelmanās syndrome (salt-losing tubulopathy). Managed with oral potassium and magnesium supplementation.
- Case 2 ā Young adult with incidental labs š§Ŗ: A 22-year-old woman is found to have persistent hypokalaemia during work-up for fatigue. She denies diuretic use. BP: 105/70 mmHg. Bloods: low potassium, low magnesium, metabolic alkalosis. Urine: low calcium excretion. Genetic testing confirms SLC12A3 mutation. Managed with electrolyte replacement and dietary salt liberalisation.
- Case 3 ā Pregnancy complication š¤°: A 28-year-old woman at 24 weeksā gestation reports paraesthesia and palpitations. ECG: U-waves consistent with hypokalaemia. Labs: hypokalaemia, hypomagnesaemia. She is normotensive, with past history of Gitelmanās. Diagnosis: exacerbation of Gitelmanās syndrome in pregnancy. Managed with aggressive potassium/magnesium supplementation and obstetricārenal team follow-up.
Teaching Point š©ŗ: Gitelmanās syndrome is a rare autosomal recessive defect of the distal convoluted tubule, mimicking thiazide diuretic use. It causes hypokalaemia, hypomagnesaemia, metabolic alkalosis, and hypocalciuria. Unlike Bartterās, it presents later (adolescence/adulthood) and is generally milder, but symptoms worsen in stress (e.g. pregnancy).